返回
摘要
En
期刊
J
IF:
0
论文数:
1.1K
被引数:
4
机构
引用论文
Impact of Vutrisiran on Cardiac Biomarkers in Patients With Transthyretin Amyloidosis With Cardiomyopathy From HELIOS-BVutrisiran对伴有心肌病的甲状腺素转运蛋白淀粉样变性患者心脏生物标志物的影响:来自HELIOS-B的研究
Serum Transthyretin as a Biomarker of Treatment Response in ATTR Cardiomyopathy血清甲状腺素结合球蛋白作为ATTR心肌病治疗反应的生物标志物
Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trialvutrisiran对患有心肌病的转甲状腺素蛋白淀粉样变性患者的心脏结构和功能的影响: helios-b试验的次要结果
Nature Medicine
IF50
Vutrisiran Improves Survival and Reduces Cardiovascular Events in ATTR Amyloid CardiomyopathyVutrisiran可改善ATTR淀粉样变性心肌病的生存率并减少心血管事件:HELIOS-B
Effects of Vutrisiran on Cardiac Function and Outcomes in Patients With Transthyretin Amyloidosis With CardiomyopathyVutrisiran对伴有心肌病的甲状腺素转运蛋白淀粉样变性患者心脏功能及结局的影响
没有更多内容

